Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs
about
Promotion of quality standard of herbal medicine by constituent removing and addingRecent advances in forensic drug analysis by DART-MSA data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples.Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in MiceThe development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human bloodThe K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs.AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in MiceCurrent applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review.Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.Analytical surveillance of emerging drugs of abuse and drug formulations.Acute kidney injury associated with smoking synthetic cannabinoid.Applications of mass spectrometry in drug metabolism: 50 years of progress.Identification of Eight Synthetic Cannabinoids, Including 5F-AKB48 in Seized Herbal Products Using DART-TOF-MS and LC-QTOF-MS as Nontargeted Screening Methods.A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.Wide-range screening of psychoactive substances by FIA-HRMS: identification strategies.Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.Analysis of legal high materials by ultra-performance liquid chromatography with time of flight mass spectrometry as part of a toxicology vigilance system: what are the most popular novel psychoactive substances in the UK?Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.Quantification of synthetic cannabinoids in herbal smoking blends using NMR.
P2860
Q28660691-C83ACFF0-1916-4FD2-8B55-42442182696FQ29395533-7BBC91CD-3676-4930-A738-EF177644771CQ30995949-23E0F3EA-9B27-435A-B52F-2404D3FC1640Q33583810-54B07150-4E74-469E-9BCE-33575574A301Q33690506-36D1FB87-DCC1-4F66-9C68-4FA6AF77D050Q33908169-BD3CD291-0E76-447F-8435-D959418F7307Q34373631-D2049FE4-46AF-4117-8A2E-88A1AFC4E667Q34419823-5D02669D-C39C-4BEB-AEA0-4487283C75A4Q34482035-872283CA-480B-4CA9-9634-A803436B70B4Q36410928-484BF83F-1030-4A20-8CFC-F34DEA9C0F9BQ37397048-78184881-4474-47D0-88FB-D684C9FBA18EQ38060039-F948EEE7-1133-40A0-8C58-10C2A8941ABBQ38236657-DA5711B7-89B8-497F-9CDE-A5A20ECD29F6Q38339664-B01D6E6B-B6F8-460F-9B7A-EB58A60218E9Q38734612-3DF2AADE-E2EC-4E86-92CF-A7DE00AD109BQ39343163-C0DDE1D3-3186-4C7F-B8D1-372B2B0AD96EQ40126502-20F49F6A-E059-44CD-A0D8-979CAF4B8FE7Q41089737-F9F704F7-BA05-4647-AA50-065812F1B3A6Q41462770-6D9DD9C5-1302-4342-B573-F399EBDD6807Q50854289-B97FE60B-C17A-41FA-94AF-FFCF8E49C93CQ51808092-53FB226E-0FCD-41F2-ABB8-1CB4E99CD198Q53063515-5010A420-4573-4FD2-BFEF-D895DEA61A7A
P2860
Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Analysis of synthetic cannabin ...... ed screening of designer drugs
@ast
Analysis of synthetic cannabin ...... ed screening of designer drugs
@en
Analysis of synthetic cannabin ...... ed screening of designer drugs
@nl
type
label
Analysis of synthetic cannabin ...... ed screening of designer drugs
@ast
Analysis of synthetic cannabin ...... ed screening of designer drugs
@en
Analysis of synthetic cannabin ...... ed screening of designer drugs
@nl
prefLabel
Analysis of synthetic cannabin ...... ed screening of designer drugs
@ast
Analysis of synthetic cannabin ...... ed screening of designer drugs
@en
Analysis of synthetic cannabin ...... ed screening of designer drugs
@nl
P2860
P50
P356
P1433
P1476
Analysis of synthetic cannabin ...... ed screening of designer drugs
@en
P2093
Wojciech L Krol
P2860
P304
P356
10.1021/AC300509H
P407
P577
2012-06-20T00:00:00Z